Table 3. Survival benefit based on the AJCC TNM stages and compliance with either the current NCCN guidelines (≥15 nodes) or with the NCDB Joinpoint (≥29 nodes).
AJCC TNM stages | Stage IA | Stage IB | Stage IIA | Stage IIB | Stage IIIA | Stage IIIB | Stage IIIC | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compliance with the NCCN guidelines (≥15 nodes retrieved) | |||||||||||||
Median survival (mon) | 126.95±9.56 | 94.26±4.83 | 91.17±3.65 | 42.58±1.82 | 28.12±0.97 | 22.67±0.79 | 20.01±1.43 | ||||||
P | <0.001 | 0.019 | <0.001 | <0.001 | <0.001 | 0.029 | |||||||
Compliance with the current NCDB Joinpoint (≥29 nodes retrieved) | |||||||||||||
Median survival (mon) | 127.51±33.82 | 126.26±26.13 | 114.46±22.95 | 52.93±4.34 | 43.22±3.09 | 25.13±1.97 | 23.56±4.26 | ||||||
P | 0.116 | 0.340 | <0.001 | 0.030 | <0.001 | 0.881 |
AJCC = American Joint Committee on Cancer; TNM = tumor, node, and metastasis; NCCN = National Comprehensive Cancer Network; NCBD = National Cancer Database.